(Q39980501)

16 September 2017

title

Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells (English)

1 reference

16 September 2017

Paulina Sokolowska

1

1 reference

16 September 2017

Jerzy Z Nowak

series ordinal

2

1 reference

16 September 2017

publication date

20 May 2008

1 reference

Journal of Molecular Neuroscience

16 September 2017

published in

1 reference

16 September 2017

volume

36

1 reference

16 September 2017

issue

1-3

1 reference

16 September 2017

page(s)

286-291

1 reference

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.

16 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-008-9071-9

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-008-9071-9

PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12031-008-9071-9

Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.

21 January 2018

1 reference

12 December 2020

A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain

1 reference

12 December 2020

Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase

1 reference

12 December 2020

VIP as a trophic factor in the CNS and cancer cells

1 reference

12 December 2020

Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation

1 reference

12 December 2020

Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins

1 reference

12 December 2020

Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems

1 reference

12 December 2020

PACAP 38 as a modulator of immune and endocrine responses during LPS-induced acute inflammation in rats

1 reference

12 December 2020

Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.

1 reference

12 December 2020

Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages

1 reference

12 December 2020

Differential Expression and Function of PACAP and VIP Receptors in Four Human Colonic Adenocarcinoma Cell Lines

1 reference

12 December 2020

Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration

1 reference

12 December 2020

Pharmaceutical VIP: prospects and problems

1 reference

12 December 2020

Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms

1 reference

12 December 2020

Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin

1 reference

12 December 2020

Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes.

1 reference

12 December 2020

PACAP(6-38) inhibits the growth of prostate cancer cells

1 reference

12 December 2020

A highly sensitive adenylate cyclase assay

1 reference

12 December 2020

Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line

1 reference

12 December 2020

PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells.

1 reference

12 December 2020

A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

1 reference

12 December 2020

VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries

1 reference

12 December 2020

PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases

1 reference

12 December 2020

VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor

1 reference

12 December 2020

Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis

1 reference

12 December 2020

Pituitary adenylate cyclase-activating polypeptide induces astrocyte differentiation of precursor cells from developing cerebral cortex

1 reference

12 December 2020

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

1 reference

12 December 2020

Possible implication of the transcriptional regulator Id3 in PACAP-induced pro-survival signaling during PC12 cell differentiation

1 reference

12 December 2020

Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies

1 reference

12 December 2020

Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression

1 reference

12 December 2020

Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

1 reference

12 December 2020

PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures

1 reference

12 December 2020

Differential effects of cAMP in neurons and astrocytes. Role of B-raf

1 reference

12 December 2020

Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.

1 reference

12 December 2020

10.1007/S12031-008-9071-9

Identifiers

DOI

1 reference

16 September 2017

1 reference